SCHEMBL7147819

SCHEMBL7147819

COc1cc2c(Nc3cccc4c(Cl)coc34)ncnc2cc1OCCCC1CCNC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.66
EGFR P00533 6/20 0.52
FGFR1 P11362 4/20 0.52
FLT1 P17948 4/20 0.52
FLT4 P35916 4/20 0.52
SRC P12931 2/20 0.51
EPHA2 P29317 6/20 0.49
HDAC3 O15379 4/20 0.48
HDAC4 P56524 4/20 0.48
HDAC1 Q13547 4/20 0.48
HDAC7 Q8WUI4 4/20 0.48
HDAC2 Q92769 4/20 0.48
HDAC10 Q969S8 4/20 0.48
HDAC11 Q96DB2 4/20 0.48
HDAC8 Q9BY41 4/20 0.48
HDAC6 Q9UBN7 4/20 0.48
HDAC9 Q9UKV0 4/20 0.48
HDAC5 Q9UQL6 4/20 0.48
EPHB4 P54760 3/20 0.48
KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7146877 0.81 SRC (0.65) KDREGFRFGFR1FLT1FLT4
SCHEMBL3677717 0.81 KDR (0.88) KDREGFRFGFR1FLT1FLT4
SCHEMBL7252484 0.81 KDR (0.66) KDREGFRFGFR1FLT1FLT4
SCHEMBL7148463 0.80 KDR (0.56) KDREGFRFGFR1FLT1FLT4
SCHEMBL7150412 0.80 KDR (0.56) KDREGFRFGFR1FLT1FLT4
SCHEMBL3675542 0.80 KDR (0.87) KDREGFRFGFR1FLT1FLT4
SCHEMBL3742346 0.80 KDR (0.87) KDREGFRFGFR1FLT1FLT4
SCHEMBL7140673 0.80 KDR (0.57) KDREGFRFGFR1FLT1FLT4
SCHEMBL3743570 0.79 KDR (1.00) KDREGFRFGFR1FLT1FLT4
Hydrochloric Acid SCHEMBL3120946 0.77 EGFR (0.74) KDREGFRFGFR1FLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326859-A1 QUINAZOLINE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY AstraZeneca AB (SE) 2003-07-16 EP claimed
WO-2002030924-A9 QUINAZOLINE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY ASTRAZENECA AB (SE) 2003-05-22 WO claimed
WO-2002030924-A1 QUINAZOLINE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY ASTRAZENECA AB (SE) 2002-04-18 WO claimed
EP-1326859-A1 QUINAZOLINE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY AstraZeneca AB (SE) 2003-07-16 EP disclosed
WO-2002030924-A9 QUINAZOLINE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY ASTRAZENECA AB (SE) 2003-05-22 WO disclosed
WO-2002030924-A1 QUINAZOLINE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY ASTRAZENECA AB (SE) 2002-04-18 WO disclosed